Arlene Blackford, OTR | |
4889 Bore Auger Rd, Blue Ridge, VA 24064-2033 | |
(540) 597-2435 | |
Not Available |
Full Name | Arlene Blackford |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 4889 Bore Auger Rd, Blue Ridge, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457557381 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 0119004548 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Arlene Blackford, OTR 4889 Bore Auger Rd, Blue Ridge, VA 24064-2033 Ph: (540) 597-2435 | Arlene Blackford, OTR 4889 Bore Auger Rd, Blue Ridge, VA 24064-2033 Ph: (540) 597-2435 |
News Archive
A growing number of patient studies show that people who suffered post-traumatic stress disorder (PTSD) are at a higher risk of developing cardiovascular diseases, including stroke and heart attack. A new review article in American Journal of Physiology—Regulatory, Integrative and Comparative Physiology examines the recent scientific literature to explain how the two are linked.
For centuries, people who've felt sick or stressed have tried drinking chamomile tea as a medicinal cure-all. Now, researchers in England have found new evidence that the popular herbal tea may actually help relieve a wide range of health ailments, including colds and menstrual cramps.
Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new therapeutic approach for the treatment of melanoma, according to results of a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research.
Despite fears of shame and stigma, most HIV-positive men choose to confide their health status to their mothers, according to a new University of Florida study. When deciding whether to tell, the men's need for their mothers' emotional and socioeconomic support outweighed those fears, researchers found.
Insero Health, Inc., a company developing natural compounds to address unmet medical needs in epilepsy and related neurological disorders, is today reporting top-line results from a Phase Ib trial of its lead compound INS001 in patients with drug-resistant epilepsy.
› Verified 2 days ago